Meridian Bioscience, Inc., incorporated on June 25, 1976, is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers. The Company’s segments include Diagnostics and Life Science. The Diagnostics segment consists of manufacturing operations in Cincinnati, Ohio, and the sale and distribution of diagnostic test kits in the countries consisting of North, Central and South America (the Americas); Europe, Middle East and Africa (EMEA), and other countries outside of the Americas and EMEA (rest of the world (ROW)). Its facility includes research, development, manufacturing, marketing, sales and distribution operations. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; Luckenwalde, Germany, and Sydney, Australia.
|Bank Name||Meridian Bioscience Inc.|
|Industry||Biotechnology: In Vitro|
|Chairman||Mr. John A. Kraeutler|
|CEO||Mr. John P. Kenny|